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2-Methylpyridine 1-oxide (S1). This compound was commercially available (CAS = 931-19-1).
It was purchased from commercial suppliers and used without further purification.
2,6-Dimethylpyridine 1-oxide (S2).
This compound was commercially availa ble (CAS = 1073-23-0). It was purchased from commercial suppliers a nd used without further purification.
2,4,6-Trimethylpyridine 1-oxide (S3).
This compound was commercially available (CAS = 3376-50-9). It was purchased from commercial suppliers and used without further purification.
3-Bromo-2-methylpyridine 1-oxide (S4).
Following the general procedure A using 3-bromo-2-methylpyridine (2.9 mmol, 500 mg) and 70% m-CPBA (2.9 mmol, 500 mg), the residue was purified by flash chromatography on silica gel (CH 2 Cl 2 -MeOH = 10:1) to afford S4 (501 mg, 92%) as a white solid. 
H NMR (400 MHz
,
3-(Ethoxycarbonyl)-2-methylpyridine 1-oxide (S5).
Following the general procedure A using ethyl 2-methylnicotinate (3.0 mmol, 500 mg) and 70% m-CPBA (3.0 mmol, 521 mg), the residue was purified by flash chromatography on silica gel (CH 2 Cl 2 -MeOH = 10:1) to afford S5 (516 mg, 95%) as a gray solid. 
2-Ethylpyridine 1-oxide (S6).
This compound was commercially available (CAS = 4833-24-3). It was purchased from commercial suppliers and used without further purification.
2-Methylquinoline 1-oxide (S7).
This compound was commercially available (CAS = 1076-28-4). It was purchased from commercial suppliers and used without further purification.
Procedure and compound characterizations
General Procedure B: In a dried 10 mL round bottom flask, equipped with a magnetic stirrer, was successfully introduced heterocycle-N-oxide (0.5 mmol), Et 3 N (1.25 mmol, 2.5 equiv) and THF (2.0 mL). The solution was cooled down at 0 º C before slowly added the aryl sulfonyl chloride partner (0.75 mmol, 1.5 equiv). Upon the addition was completed, the solution was raised to room temperature and stirred over 16 h. The precipitate (Et 3 NHCl) was removed via a filtration through a pad of silica, and washed with ethyl acetate 3 times. The crude mixture was concentrated before to be purify using flash column chromatography on silica gel. 
Methyl3-(((6-methylpyridin-2-yl)methoxy)sulfonyl)thiophene-2-carboxylate (7).
Following the general procedure B using 2,6-dimethylpyridine 1-oxide (0.5 mmol, 62 mg) and methyl 3-(chlorosulfonyl)thiophene-2-carboxylate (0.75 mmol, 180 mg), the residue was purified by flash chromatography on silica gel (Pentane-EtOAc = 3:1) to afford 7 (88 mg, 54 %) as colorless liquid. This is a known compound and the spectral data are identical to those reported in literature. This is a known compound and the spectral data are identical to those reported in literature. In a second step, the residue was dissolved in THF (2 mL), and Et 3 N (0.5 mmol, 1.0 equiv) was added. The solution was cooled down to 0 o C and aryl sulfonyl chloride (0.75 mmol, 1.5 equiv) was slowly added. Upon the addition was completed, the solution was raised to room temperature and stirred over 16 h. The mixture was then poured in aqueous HCl (1M, 10 mL).
The aqueous layer was extracted with ethyl acetate (3 x 15 mL) and the combined organic layers were washed with brine (100 mL), dried (Na 2 SO 4 ), filtered and evaporated in vacuo before to be purify using flash column chromatography on silica gel. This is a known compound and the spectral data are identical to those reported in literature. This is a known compound and the spectral data are identical to those reported in literature. This is a known compound and the spectral data are identical to those reported in literature. This is a known compound and the spectral data are identical to those reported in literature. This is a known compound and the spectral data are identical to those reported in literature.
2-Oxo-2-phenylethyl 4-methylbenzenesulfonate (14)
3
N-ethyl-N-((6-methylpyridin-2-yl)methyl)ethanamine (19).
To a solution of (6-methylpyridin-2-yl)methyl-4-methylbenzenesulfonate (0.2 mmol, 55 mg) in THF (2 mL) was added diethylamine (10 mmol, 730 mg). The resulting solution was stirred at room temperature overnight. Then, the resulting precipitate was removed via a filtration through a pad of silica, and washed with ethyl acetate 3 times. The crude mixture was concentrated before to be purify using flash column chromatography on silica gel (Pentane-EtOAc = 1:1) to afford the 19 (27 mg, 75 %) as colorless oil. This is a known compound and the spectral data are identical to those reported in literature. DMF was removed using high vacuum and the residue was redissolved in EtOAc.
H NMR (400
Then, the resulting precipitate was removed via a filtration through a pad of silica, and washed with ethyl acetate 3 times. The crude mixture was concentrated before to be purify using flash column chromatography on silica gel (Pentane-EtOAc This is a known compound and the spectral data are identical to those reported in literature. This is a known compound and the spectral data are identical to those reported in literature. +.
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